General Information |
|
| NSE Symbol* | LALPATHLAB |
| Name of the Company* | DR. LAL PATH LABS LTD. |
| ISIN* | INE600L01024 |
| Type of Meeting |
1) Board Meeting |
| Details of Committee Meeting or Other Type of Meeting | |
| Type of Intimation* | New |
| Reason for Re-schedule (postpone or prepone) / Cancellation | |
| Proposed Meeting Date | 2025-10-31 |
| Original Meeting Date | |
| Whether trading window is closed* | Yes |
| Trading Window Closure- Start date | 2025-10-01 |
| Details of Trading Window Closure End date | 2025-11-02 |
| Short Notice | |
| Date of Report* | 2025-10-24 |
Agenda Details |
|
| Agenda* |
1) Financial results 2) Dividend 3) Bonus 4) Other business |
| Whether results are audited or unaudited | Unaudited |
| Nature of report standalone or consolidated | Standalone And Consolidated |
| Period end Type | Quarterly |
| Period up to (Month) | September |
| Period up to (Year) | 2025 |
| Mode of raising Funds | |
| Type of Dividend |
1) Interim |
| Remarks (website dissemination) | The meeting of the Board of Directors is scheduled to be held on Friday, October 31, 2025 to inter-alia: 1.Consider and approve Un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Half Year ended September 30, 2025; 2.Consider declaration of 2nd Interim Dividend, if any, on the Equity Shares of the Company for the Financial Year 2025-26; & 3.Consider issuance of bonus shares in accordance with the applicable provisions and subject to approval of Shareholders of the Company. |